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Summary. Chronic renal diseases often degenerate 
towards end-stage failure, requiring replacement renal 
therapy. The progressive decline of such diseases is a 
highly complex, multi-factorial process, which is poorly 
understood. Indeed, not all chronic conditions take on a 
progressive course, some may recover to regain normal 
function, while others may remain functionally impaired 
yet stable. The structural features of progressive decline, 
however, show common histological features, despite 
the diverse nature of the primary injury. These aberrant 
structural alterations are characterised essentially by a 
dramatic expansion of the tubulointerstitium, with 
accompanying tubular atrophy, resulting from interstitial 
fibrosis. These changes are thought to be a uniform 
response to prolonged inflammation which may 
originate in the glomerulus, the vasculature or the 
interstitial space (Strutz et al., 1995). 
A histomorphometric analysis of renal diseases, 
initially performed by Risdon et al .  (1968), and 
supported by Bohle et al. (1987) and others (Eknoyan et 
al., 1990), revealed that the severity of abnormal 
glomerular pathology did not always correlate directly 
with impaired renal function. The extent of interstitial 
inflammation and the degree of interstitial fibrosis, 
however, were both shown to be more accurate 
predictors of renal function (Bohle et al., 1992). 
Furthermore there was a high probability of irreversible 
functional decline, in the presence of interstitial fibrotic 
lesions and tubular atrophy. Interstitial fibrosis is 
therefore considered an important histological marker 
for end stage renal failure, and is believed to be 
functionally more significant than primary changes 
within the glomerulus. 
In most tissues, resident fibroblasts are believed to 
be the cells principally responsible for the synthesis and 
breakdown of extracellular matrix (ECM) within ' 
connective tissues. Indeed in fibrotic diseases of lung 
and skin, the resident fibroblast has been identified as 
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the most important cell responsible for the abnormal 
deposition of ECM components during the disease 
process (Phan et al., 1985). In the kidney, there are 
probably several sources of matrix components during 
fibrosis including tubular epithelia1 cells, inflammatory 
macrophages (Vaage and Linbland, 1990) as well as 
interstitial fibroblasts. Although the precise cellular 
source of the bulk of this matrix requires clarification, 
there is mounting evidence supporting a significant 
contribution from resident or infiltrating fibroblasts 
(Rodemann and Muller, 1990, 1991a,b; Strutz and 
Muller, 1995). 
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Characterisation of renal cortical fibroblasts 
Fibroblasts in a varietv of fibrosed tissues. have been 
described as possessing iome of the morphological and 
functional characteristics of smooth muscle cells. 
Initially described in granulation tissue of experimental 
skin wounds, these myofibroblastic cells, appeared 
transiently at the wound edge, and were characterised by 
the presence of a-smooth muscle actin (aSMA) positive 
cytoplasmic microfilaments (Darby et al., 1990). It was 
these myofibroblasts which were shown to provide the 
force for wound contraction (Skalli et al., 1989; Grinnell 
1994). During the progression of pulmonary fibrosis, 
increasing numbers of myofibroblasts, at sites of fibrotic 
injury have been described (Khun and McDonald, 1991). 
Myofibroblastic cells have also been described in 
kidneys. During the progression of experimental 
nephritis (Zhang et al., 1995), there was an increasing 
myofibroblast population within the renal interstitium. 
Fibrotic progression, in this model, was associated with 
increased immunohistological staining for aSMA, both 
within the glomerulus and the interstitium, and these 
changes paralleled those of matrix deposition. 
Immunoelectron microscopy revealed a small population 
of fibroblastic interstitial cells which constitutively 
expressed aSMA in normal human kidneys (Alpers et 









